Acute Myeloid Leukemia with MYC Amplification on a Ring Chromosome 8  Internal Medicine. 2025;64(21):3135–3139
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40254434

Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial  BMJ. 2025;391:e084314
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41120215

Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST  International Journal of Hematology. 2025;122(5):647–659
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40418277

Autoimmune hemolytic anemias : a practical guide. Elsevier Inc.; 2025 
Available from: https://login.smhslibresources.health.wa.gov.au/login?url=https://www.clinicalkey.com.au/dura/browse/bookChapter/3-s2.0-C2023052436X

Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis  Annals of Medicine. 2025;57(1):2445192
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39707826

Cardiac Events in Three Phase 3 Randomized Trials Including Acalabrutinib in Chronic Lymphocytic Leukemia  Clinical Lymphoma, Myeloma & Leukemia. 2025;25(11):819–828.e5
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40413154

Characterizing VEXAS syndrome in women: Findings from an international multicenter study  Journal of Internal Medicine. 2025;298(5):516–524
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40985189

Dyskeratosis Congenita Complicated by Pulmonary Fibrosis and Myelodysplastic Syndrome with a Germline Mutation of the DKC1 Gene and a Somatic Mutation of the U2AF1 Gene in Leukocytes  Internal Medicine. 2025;64(20):3000–3006
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189296

Effect of roxadustat on lowering blood lipids in peritoneal dialysis patients with anemia  Renal Failure. 2025;47(1):2460726
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40000368

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL Blood. 2025;146(18):2168–2176
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40737596

Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021  Lancet. 2025;404(10471):2543–2583
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39667386

Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase ½ (FANCOLEN-1) and long-term clinical trials  Lancet. 2025;404(10471):2584–2592
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39642902

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial Blood. 2025;146(15):1747–1758
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40499010

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia Blood Adv. 2025;9(20):5123–5133
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40590852

Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia  JAMA. 2025;334(14):1267–1277
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40952748

Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML  Blood. 2025;146(15):1862–1867
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40768751

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML Blood Adv. 2025;9(20):5177–5189
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40706052

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency  New England Journal of Medicine. 2025;393(15):1486–1497
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41092330

Obinutuzumab-induced Acute Thrombocytopenia Mimicking Immune Thrombocytopenia in a Patient with Follicular Lymphoma  Internal Medicine. 2025;64(20):3007–3011
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40222942

Prenatal Intravenous Iron and Child Growth: A Secondary Analysis of a Randomized Clinical Trial  JAMA Netw Open. 2025;8(10):e2538392
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41148141

Proton Pump Inhibitors for Inducing and Maintaining Remission in Eosinophilic Esophagitis: An Updated Systematic Review and Meta-Analysis  Clinical Gastroenterology and Hepatology. 2025;23(12):2115–2127.e21
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40089255

Successful Salvage Therapy with Pomalidomide, Cyclophosphamide, and Dexamethasone for IgM Myeloma with t (11;14) and Dim CD38 Expression Refractory to Daratumumab, Lenalidomide, and Dexamethasone Internal Medicine. 2025;64(20):3020–3026
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301030

Successful Treatment of Refractory TAFRO Syndrome with Cyclophosphamide: A Report of Two Cases  Internal Medicine. 2025;64(21):3130–3134
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40254431

Systematic Literature Review of DOACs as Treatment for Confirmed or Suspected Heparin-Induced Thrombocytopenia (HIT)  Annals of Pharmacotherapy. 2025;59(11):1015–1030
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40411430

Vitamin C Deficiency Megaloblastic Anemia Mimicking Hemolytic Anemia  Internal Medicine. 2025;64(21):3140–3145
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40301046